Internal Medicine, Medical Oncology · Seattle, WA
NPI
1346562816
Since 2010
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
1221 Madison St Ste 1020
Seattle, WA, 98104
Phone (206) 386-9501
Groups this clinician bills Medicare through
Medicare paid, 2024
$88K
1,549 services
Medicare patients, 2024
278
Average age 77
Drug cost, 2024
$6.7M
2,684 prescriptions
Company payments, 2025
$8,266
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Song Zhao was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 590 times for 235 patients. In total Song Zhao billed 1,549 services in 13 codes, and Medicare paid $88K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-22.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 590 | 235 | $13.65 | $8,052 |
| 99214 Office E&M - Established | Facility | 386 | 187 | $75.33 | $29K |
| 99215 Office E&M - Established | Facility | 317 | 134 | $111.51 | $35K |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 104 | 58 | $26.03 | $2,707 |
| 99213 Office E&M - Established | Facility | 72 | 56 | $50.48 | $3,635 |
| 99205 Office E&M - New | Facility | 55 | 55 | $141.14 | $7,763 |
By year: 2022 $88K for 992 services; 2023 $92K for 1,105 services; 2024 $88K for 1,549 services.
Medicare prescription drug claims, 2024
In 2024, the drug Song Zhao prescribed most often to Medicare patients was Abiraterone Acetate, with 699 prescriptions and refills. In total Song Zhao wrote 2,684 Medicare prescriptions that cost $6.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Abiraterone Acetate Generic | 699 | 763 | 87 | $862K |
| Prednisone Generic | 592 | 802 | 102 | $3,120 |
| Dexamethasone Generic | 173 | 230 | 38 | $1,156 |
| Orgovyx Relugolix | 143 | 143 | 26 | $378K |
| Xtandi Enzalutamide | 116 | 116 | 21 | $1.6M |
| Tamsulosin Hcl Generic | 95 | 183 | 24 | $776 |
| Bicalutamide Generic | 95 | 159 | 57 | $1,904 |
| Nubeqa Darolutamide | 90 | 90 | 13 | $1.2M |
| Hydroxyurea Generic | 61 | 132 | 13 | $1,769 |
| Cabometyx Cabozantinib S-Malate | 58 | 58 | Under 11 | $1.5M |
| Oxycodone Hcl Generic | 45 | 45 | Under 11 | $288 |
| Prochlorperazine Maleate Generic | 37 | 37 | 21 | $505 |
| Gabapentin Generic | 35 | 51 | 14 | $372 |
| Levothyroxine Sodium Generic | 29 | 38 | Under 11 | $71.61 |
| Talzenna Talazoparib Tosylate | 25 | 25 | Under 11 | $276K |
Brand drugs: 548 claims; generic drugs: 2,136 claims; opioid claims: 83.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Song Zhao $8,266 ($5,066 in general payments such as food, travel and fees and $3,200 for research) from 14 companies. The largest payer was Pfizer Inc. with $3,200.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 1 | $3,200 |
| Eisai Inc. 4523.T | 1 | $2,400 |
| Janssen Biotech, Inc. JNJ | 1 | $1,263 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $890 |
| Procept Biorobotics Corporation PRCT | 1 | $135 |
| Genentech, Inc. ROG.SW | 1 | $132 |
| Janssen Scientific Affairs, LLC JNJ | 1 | $112 |
| Sumitomo Pharma America, Inc. 4506.T | 2 | $108 |
| Daiichi Sankyo Inc. 4568.T | 1 | $26.41 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.